Skip to main content

Table 3 Acute change from baseline in blood pressure and biomarkers

From: The effect of an apple polyphenol extract rich in epicatechin and flavan-3-ol oligomers on brachial artery flow-mediated vasodilatory function in volunteers with elevated blood pressure

 

Apple extract treatment

Placebo treatment

Variable

Change

Mean (SD), pre

Mean (SD), post

Change

Mean (SD), pre

Mean (SD), post

Systolic blood pressure, mm Hga

−0.6

145.4 (13.2)

145.3 (15.5)

−1.6

148.2 (15.1)

146.7 (14.5)

Diastolic blood pressure, mm Hga

−0.6

90.3 (7.1)

89.7 (8.0)

0.3

90.3 (7.0)

90.8 (7.1)

s-ICAM-1, pg/mlb

−8658

267,737 (52847)

259,086 (50958)

−5339

264,810 (58029)

259,375 (54260)

sVCAM-1, pg/mlb

−0.10 (log)

1,555,001 (520492)

1,415,276 (561821)

−0.07 (log)

1,494,420 (500826)

1,384,356 (422927)

PAI-1, pg/mlb

0.07 (log)

55,433 (28812)

61,956 (39638)

0.09 (log)

53,976 (27527)

58,703 (29755)

C-reactive protein, pg/mlb

−0.10 (log)

2,791,200 (9722821)

1,230,700 (1189128)

0.02 (log)

1,396,497 (2464468)

1,530,123 (2079646)

ADMA, μmol/lb

0.005

0.776 (0.175)

0.790 (0.144)

−0.012

0.791 (0.155)

0.780 (0.154)

vWf, ng/mlb

0.009 (log)

64,201 (40893)

71,662 (71789)

0.013 (log)

58,823 (40455)

65,056 (55217)

sE-selectin, pg/mlb

0.09 (log)

689.2 (315.4)

751.8 (295.6)

0.13 (log)

649.9 (279.8)

741.3 (301.3)

  1. aChange from baseline at end-of-treatment period (based on ANCOVA-model)
  2. bChange in pre-dose measurements between end and start of the treatment period (based on ANCOVA-model)